Abstract Treatment-resistant depression affects at least 1-3% of the US population. This article reviews the current state of focal neuromodulation therapies for treatment-resistant depression, focusing on those treatments published clinical data. These include transcranial magnetic stimulation, transcranial direct current stimulation, magnetic seizure therapy, vagus nerve stimulation, direct cortical stimulation, and deep brain stimulation among others. […] Read more…
Mark S. George, Joseph J. Taylor, and E. Baron Shor INTRODUCTION Transcranial magnetic stimulation (TMS) is perhaps the most popular of the new brain stimulation techniques because its clinical effects are produced without the need for a craniotomy [as with deep brain stimulation (DBS)] or seizure induction [as with electroconvulsive therapy (ECT)]. As a focal, […] Read more…
Abstract INTRODUCTION: Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center. Transcranial magnetic stimulation (TMS) is a US Food and Drug Administration-approved treatment for major depressive disorder (MDD) in patients who have not responded to […] Read more…
Author: Batya Swift Yasgur, MA, LSW Date: July 31, 2019 “Deep” repetitive transcranial magnetic stimulation (rTMS) plus standard antidepressant medication is significantly more effective at reducing depression levels in patients with major depressive disorder (MDD) than standard rTMS or stand-alone pharmacotherapy, new research suggests. In a randomized study, almost 230 participants with treatment-resistant depression (TRD) received either […] Read more…
Self-Care: An Essential Part of Your Mental Health Toolkit Self-care seems like a buzzword nowadays. It’s topic that’s on the cover magazines and in self-help articles all the time. But, even though it’s a trending topic, doesn’t mean you should dismiss it with an eye roll. In fact, self-care should be an essential part of […] Read more…
Amanda Itzkoff MD and NYC Psychiatry are pleased to announce they’re now accepting new patients for intranasal esketamine (SPRAVATO™) treatment. What is SPRAVATO™ ? SPRAVATO™ is a prescription medicine, used along with an antidepressant taken by mouth, for treatment-resistant depression (TRD) in adults. SPRAVATO™ is not for use as a medicine to prevent or relieve pain […] Read more…
Shocking, scary, life-threatening, and dangerous events are the stories that make news headlines across the world. But, for survivors of these traumas, they can have a lasting impact that causes emotional turmoil. The nightmares, flashbacks, sadness, numbness, loss of interest, and serve anxiety are just a few ways PTSD can cause significant distress in occupational, […] Read more…
In the medical field, 175 years is a long time. It probably goes without saying that there have been some major advancements in medicine over the passing decades. Medicines and treatments that brought innovative care, a deeper understanding, and relief for those suffering from common mental illnesses. For these reasons (and more!), we celebrate the […] Read more…
Remission rate was significantly greater in HF-rTMS groups compared to the control. Main-analyses showed no difference in remission rate between H1-coil, and 8-coil group. Better response rate and reduction of depression severity was observed in H1-coil, then in 8-coil group, although H1-coil protocol uses a smaller number of pulses and has a shorter duration of […] Read more…
2019 is off to a great start! New research and developments in psychiatric care help pave the way to enhanced treatment options for common mental illnesses. These advancements offer life-changing possibilities to those who need something more than standard protocol. Here’s a quick recap… Esketamine’s FDA Approval The FDA’s approval of esketamine (Spravato) nasal spray […] Read more…